Please read and agree to the terms and conditions of this site.
@techcrunch.com 1 year ago
Nanopath is looking to drastically change medical diagnostics
@xconomy.com 4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com 5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com 5 years ago
Celsee Charts Expansion Plans as Single-Cell Analysis Demand Grows
@xconomy.com 5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@techcrunch.com 5 years ago
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
@xconomy.com 5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?